Alexandria Park at 128
available to Lease
in Bedford, Massachusetts
posted on November 29, 2012
Director of Economic Development
Preston Court has undergone a major renovation which now features a superior "laboratory ready" infrastructure. Alexandria Real Estate Equities has also recently completed two "spec lab" suites of approximately 7,500 RSF each located on the 1st floor.
3 Preston Court is conveniently located off of Route 128 at the sought-after interchange of Route 4/225 (Exit 31).
The facility is located off Wiggins Avenue on the Lexington/Bedford town line, near Hartwell Avenue and only a couple of miles from Route 128 at Exit 31 (Route 4/225) off Route 128/Interstate 95. The surrounding area, well known for many years as a hi-tech center, has become home to many firms engaged in the science and technology industry. Shire, Johnson & Johnson and Synta Pharmaceuticals are just a few of the many firms that have chosen this area to locate their office and laboratory facilities.Lexington.
Biotech Infrastructure Amenities
2.5 spaces per 1,000 SF
33 watts/sf available
Town: sewer & water; Keyspan: gas; NStar: electric
5 watts/sf emergency power
24 fume hoods without face velocity controls.
Provisions for RODI, compressed air and vacuum systems
Life Tech, Millipore, Toxicon, Synta Pharmaceuticals, QD Vision, Anika Therapeutics, TIAX
|Property Use||Lab, Office|
|Parking||This property has parking available|
|Building Size (in Square Feet)||30,123|
|Square feet available||16,030|
|Date of Construction||1974|
|Property Owner||Alexandria Real Estate Equities|
Images (Click on images to view larger size)
MassBio is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.
Founded in 1985, MassBio represents over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, and works to advance policy and promote education, while providing member programs and events, industry information, and services.
- December 9, 2014 Q & A with Dr. David Meeker, President and Chief Executive Officer of Genzyme
- December 9, 2014 Preparing the State's Next Generation of Biotechnology Leaders
- December 9, 2014 Personal Tragedy Calls Parents to Action
- December 9, 2014 MassCONNECT Graduates Celebrate Success
- December 9, 2014 Patient Advocacy Summit 2014: Live & Breathe